MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • MassDevice Today
    • Cardiovascular
    • Clinical Trials
    • Legal News
    • Orthopedics
    • Regulatory/Compliance
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • More MedTech
    • Cosmetic/Aesthetic
    • Diabetes
    • Dialysis
    • Distribution
    • Imaging
    • Otolaryngology Ear, Nose & Throat
    • Pharma
    • Respiratory
    • Wound Care
  • Blog
  • DeviceTalks Podcasts
  • Resources
    • About MassDevice
    • Job Board
    • Leadership in Medtech
    • Manufacturer Search
    • White Papers
  • DeviceTalks
Home » Smith & Nephew touts results from Allevyn Life adhesive dressing hip fracture trial

Smith & Nephew touts results from Allevyn Life adhesive dressing hip fracture trial

February 15, 2018 By Fink Densford Leave a Comment

Share

Smith & Nephew

Smith & Nephew (NYSE:SNN) today released the results from a trial of its Allevyn Life multi-layer silicone adhesive foam dressing, touting that its addition to standard care protocols reduces the onset of pressure ulcers by 71% in elderly patients being treated for hip fracture.

The trial was published in the International Wound Journal, the London-based company said.

“Hip fractures in the elderly are a serious problem due to the high rate of mortality and complications such as pressure ulcers, which occur mainly in the sacral area. Preventive measures play an important role in increasing quality of care, reducing health costs and improving the patient’s quality of life. Our research shows that Allevyn Life is effective at reducing the rate of pressure ulcers in the sacrum in elderly patients with hip fracture. The excellent adhesiveness of this device also enables costs to be kept down,” Cristiana Forni of Bologna, Italy’s Rizzoli Orthopaedic Institute said in a prepared statement.

Data in the trial came from an analysis of 359 fragile hip patients of age 65 or over, with patients divided into a treatment cohort that received the Allevyn Life and those who treated standard care.

Results indicated that 15.4% of patients who received only standard care developed pressure ulcers, while 4.5% of the Allevyn Life cohort developed ulcers, indicating a 71% reduction in pressure ulcer incidence.

The Allevyn Life dressing features five layers, with a breathable top layer, hydrocellular layer, an absorbent lock away core, masking layer and silicone gel adhesive layer, Smith & Nephew said.

“Many global experts and professional bodies8 state polyurethane foam dressings should be considered for use prophylactically on bony prominences in anatomical areas subject to friction and shear. This new research further demonstrates that Allevyn Life is a safe and effective preventative measure suited to be at the heart of a pressure ulcer prevention strategy,” chief medical officer Dr Andy Weymann said in a press release.

Last month, Smith & Nephew touted a 97.3% decrease in readmission rates for joint arthroplasties using its Episode of Care Assurance Program, a bundled payment option designed to reward good patient outcomes.

Filed Under: Clinical Trials, Orthopedics, Wound Care Tagged With: Smith & Nephew

In case you missed it

  • NuVasive files alleged poaching, infringement suits against Alphatec
  • Smith & Nephew touts results from Allevyn Life adhesive dressing hip fracture trial
  • Stryker wins expanded FDA indications for Trevo thrombectomy device
  • Zimmer Biomet, Plaintiffs look to settle roughly 300 NexGen knee cases
  • Tandem Diabetes touts pivotal study of insulin pump with low glucose suspend feature
  • Icon reports more expectation-beating results
  • Acelity to layoff 68 San Antonio employees
  • Medtronic looks to expand MiniMed 670G into pediatric diabetes
  • Acorda posts Q4 revenue beat, but misses EPS estimates
  • BD closes $100m biopsy assets divestiture to Merit Medical
  • Exactech closes $737m go-private sale to TPG Capital
  • Edwards Lifesciences wins CE Mark for Centera TAVR
  • After 20 years, Paratek’s broad-spectrum antibiotic is headed to the FDA
  • DreaMed Diabetes wins CE Mark for insulin therapy management platform
  • LivaNova to buy TandemLife in deal worth up to $250m
  • Motus GI downsizes IPO to $18m
  • Stryker nears closure of Vexim takeover, passes 95% ownership

RSS From Medical Design & Outsourcing

  • Icon reports more expectation-beating results
    Medtech, pharma and biotech development outsourcer Icon continues to beat the Street when it comes to its results. Dublin, Ireland–based Icon (Nasdaq:ICLR) said today that it earned $78.5 million, or $1.43 per share, off $455.1 million in sales for the fourth quarter ended Dec. 31, 2017 – up from $74.3 million, or $1.33 per share, in […]
  • NIH offers $1 million prize in human retina prototype competition
    The National Institutes of Health (NIH) has created a $1 million prize competition to challenge people to build functioning human retina prototypes to help in the fight against blindness. The National Eye Institute 3D Retina Organoid Challenge is designed to create lab-grown human retinas from stem cells that replicate the structure, organization and function of […]
  • Zeiss announces partnership with software outfit Xnovo Technology
    Zeiss Microscopy recently announced an exclusive strategic partnership agreement with Xnovo Technology, a Danish company developing software-based 3D X-ray imaging and analysis products. Zeiss and Xnovo have already been working together for two years. The strategic partnership, announced earlier this month, is meant to advance and expand the laboratory-based diffraction contrast tomography technique on the Zeiss […]
  • This smartphone case monitors blood glucose on the go
    University of California San Diego engineers have created a smartphone case that, when paired with an app, can make it easier for people with diabetes to track and record blood glucose levels on the go. “Integrating blood glucose sensing into a smartphone would eliminate the need for patients to carry a separate device,” Patrick Mercier, […]
  • MD&M West: 10 technologies you should know
    MD&M West is one of the largest medical device manufacturing events in the world, so it’s easy to get lost on the show floor. Even if you were in Anaheim, Calif., for the event last week, you may have missed a lot. From a new robotics insights display from Rethink Robotics to a disinfectant-resistant plastic […]
  • Report: Amazon gearing up for entry into medical supplies biz
    Amazon (NSDQ:AMZN) is looking to up the ante in its medical supplies business and turn the unit into a major supplier to US hospitals and clinics, according to a Wall Street Journal report. The online mega retailer has initiated a trial of a new system testing to see if it can use its Amazon Business site to supply […]
  • Rethink Robotics wants to make advanced manufacturing smarter: Here’s how
    Rethink Robotics is touting a value-add to its Sawyer manufacturing robots: a new feature called Intera Insights that displays key performance indicators (KPIs) on a customizable on-robot display, as well as on smart devices on the same network. Think easy access to metrics including cycle time, part count, speed and force. “Instead of just having it be ones and […]
  • Spectrum Plastics Group buys Apex Resource Technologies
    Spectrum Plastics Group (Alpharetta, Ga.) is expanding its specialty products and design engineering offerings through its acquisition of Apex Resource Technologies. Financial terms of the deal were not disclosed in today’s announcement. Apex has more than 60 people at its 45,000-square-foot facility in Pittsfield, Mass., and is a full-service design engineering, tooling and injection molding operation. […]
  • Could this Eastman polymer improve medical device housing durability?
    Specialty plastics provider Eastman used the recent MD&M West to tout the ability of its MXF221 copolyester to hold up to repeated application of hospital disinfectants. Eastman officials think MXF221 could be a new option for medical device manufacturers – especially because a cracked housing could endanger the electronics inside expensive equipment including ultrasound and […]
  • Ultrasound imaging and blood tests could catch liver cancer in early stages
    Researchers at the University of Texas Southwestern have recently discovered that combining ultrasound images with blood tests that test for high alpha fetoprotein (AFP) levels can improve detection of early-stage liver cancer by 40%. There are about 42,220 new liver cancer diagnoses and about 30,200 will die from it per year. It affects more men […]
  • MasterControl thinks it can speed up validation: Here’s how
    MasterControl officials are touting cloud-based software-as-a-service as a way for medical device manufacturers to speed up validation processes. Their first validation excellence tool (VxT) involves risk-based software validation. The VxT — which MasterControl (Salt Lake City) showed off last week at MD&M West in Anaheim, Calif. — is a value-add on top of MasterCloud’s software solutions. […]

Leave a Reply Cancel reply

You must be logged in to post a comment.

Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Tweets by @MassDevice

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing

MASSDEVICE

Subscribe to MassDevice
Advertise with us
About
Contact us
Privacy
Add us on FacebookMassDevice Network
Follow us on Twitter@MassDevice
Connect with us on LinkedInLinkedIn
Connect with us on Google PlusGoogle+

Copyright © 2018 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy